Strata Skin Sciences (SSKN) Stock Price, News & Analysis

Company Overview

Strata Skin Sciences, Inc. is a medical technology company headquartered in Edison, New Jersey, that specializes in developing and commercializing dermatological devices and therapies. The company’s flagship offering is the XTRAC® excimer laser system, an FDA‐cleared, 308-nanometer ultraviolet light device used to treat skin conditions such as vitiligo and psoriasis. Strata’s product suite also includes associated accessories and disposables, as well as clinical services and training programs designed to support dermatology practices and improve patient outcomes.

Strata Skin Sciences expanded its portfolio and market presence through the strategic acquisition of PhotoMedex in 2019, bringing together complementary phototherapy and energy-based technologies under one roof. This integration enabled the company to widen its geographic footprint, serving physicians and clinics across the United States and through select international distribution partners in Europe and Asia. Strata continues to invest in clinical research, product enhancements and next-generation platforms aimed at addressing a range of dermatologic disorders with noninvasive treatment modalities.

Under the leadership of Chairman and Chief Executive Officer David J. Peskin, Strata Skin Sciences maintains a direct sales force of clinical specialists who provide installation, training and ongoing support for its laser and light‐based systems. The company’s operational strategy focuses on fostering long-term partnerships with dermatology practices, promoting the adoption of its technologies through peer-reviewed publications, educational initiatives and real-world evidence studies. As a result, Strata has positioned itself as a focused provider of advanced phototherapy solutions within the skin disease market.

Key Stats

• Today's Range: $1.64 to $1.77
• 50-Day Range: $1.39 to $2.83
• 52-Week Range: $1.38 to $3.86
• Volume: 112,063 shs
• Average Volume: 5.52 million shs
• Market Capitalization: $9.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Hold

Strata Skin Sciences Stock Analysis - MarketRank™

Strata Skin Sciences scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Strata Skin Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Strata Skin Sciences has a consensus price target of $6.00, representing about 250.9% upside from its current price of $1.71.

Amount of Analyst Coverage

Strata Skin Sciences has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Strata Skin Sciences is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Strata Skin Sciences is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Strata Skin Sciences has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.91% of the float of Strata Skin Sciences has been sold short.

Short Interest Ratio / Days to Cover

Strata Skin Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Strata Skin Sciences has recently increased by 181.05%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Strata Skin Sciences does not currently pay a dividend.

Dividend Growth

Strata Skin Sciences does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.91% of the float of Strata Skin Sciences has been sold short.

Short Interest Ratio / Days to Cover

Strata Skin Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Strata Skin Sciences has recently increased by 181.05%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.37

News Sentiment

Strata Skin Sciences has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Strata Skin Sciences this week, compared to 2 articles on an average week.

Search Interest

105 people have searched for SSKN on MarketBeat in the last 30 days. This is an increase of 338% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

39.00% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 32.43% of the stock of Strata Skin Sciences is held by institutions.

SSKN Stock Analysis - Frequently Asked Questions

How have SSKN shares performed this year?

Strata Skin Sciences' stock was trading at $2.91 at the beginning of 2025. Since then, SSKN shares have decreased by 41.2% and is now trading at $1.71.

How were Strata Skin Sciences' earnings last quarter?

Strata Skin Sciences, Inc. (NASDAQ:SSKN) issued its quarterly earnings data on Wednesday, August, 13th. The medical device company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by $0.33. The medical device company had revenue of $7.70 million for the quarter, compared to analysts' expectations of $8.56 million. Strata Skin Sciences had a negative net margin of 35.13% and a negative trailing twelve-month return on equity of 266.94%.
Read the conference call transcript.

When did Strata Skin Sciences' stock split?

Strata Skin Sciences's stock reverse split on the morning of Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Strata Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Strata Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 8/13/2025
• Today: 10/25/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SSKN
• CIK: 1051514
• Web: www.strataskinsciences.com
• Phone: (215) 619-3200
• Fax: 215-619-3208
• Employees: 120
• Year Founded: 1989

Price Target and Rating

• Average Price Target for Strata Skin Sciences: $6.00
• High Price Target: $6.00
• Low Price Target: $6.00
• Potential Upside/Downside: +250.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.84)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.09 million
• Net Margins: -35.13%
• Pretax Margin: -35.65%
• Return on Equity: -266.94%
• Return on Assets: -32.66%

Debt

• Debt-to-Equity Ratio: 49.58
• Current Ratio: 0.98
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: $33.56 million
• Price / Sales: 0.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.19 per share
• Price / Book: 1.44

Miscellaneous

• Outstanding Shares: 5,270,000
• Free Float: 3,214,000
• Market Cap: $9.01 million
• Optionable: Not Optionable
• Beta: 0.50